Discovery Research Services and Products

  1. Medicinal And Synthetic Chemistry 9/19/2023

    Explore the comprehensive support and expertise available for your drug discovery process.

  2. Apollo™ 8/18/2023

    Apollo™ is an innovative platform that empowers you with real-time access to study data, milestones, documents, and program planning tools.

  3. SUREmAb — Monoclonal Antibody Development, The Way It's Meant To Be 8/4/2023

    Leverage robust development strategies and enable an optimized process for mAb development and manufacturing, efficiency and speed with exceptional quality, and high titers with lower-cost workflows for maximum ROI.

  4. SUREtechnology Platform™ 8/4/2023

    Explore how an advanced Cell Line Development (CLD) platform for new biologics can enable CHO-based cell line development; ensure premium, stable, and high-yield results; overcome common expression bottlenecks; and provide robust verification, genomic characterization, and monoclonality assessment services.

  5. Integrated Drug Discovery 7/1/2023

    Finding a partner with integrated services is crucial for accelerating timelines and accessing solutions with comprehensive expertise, all while removing risk from the drug product lifecycle.

  6. Safety Assessment Services 6/20/2023

    A full range of in vivo and in vitro testing services that can be customized for your project’s needs to expedite preclinical development while maintaining a high quality standard.

  7. One Step 6/20/2023

    Make strides with a tailored, comprehensive suite of discovery and development services to rapidly progress your project and reduce time to market.

  8. PUREplatform PUREcoli, A Pure Microbial Strain For Protein Production 3/17/2023

    PUREplatform offers a platform, a premium strain, and cutting-edge screening, which together yield optimal protein expression that is uniquely tailored to each project.

  9. Cell Line Development 2/17/2022

    Our experience developing mammalian and microbial cell lines and our analytical capabilities enable us to identify and select clones that meet your product’s specific parameters and characteristics.

  10. Rapid Development Through Phase I CTM 1/28/2022

    Ascendia works with discovery-stage pharmaceutical companies to provide lab-scale formulations suitable for pre-clinical testing. We conduct pre-formulation assessments, bioavailability modeling, and formulation approach comparisons. We provide trial formulations suitable for animal studies, toxicology studies, and cGMP clinical trial materials for Phase I studies.